A citation-based method for searching scientific literature

Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
Times Cited: 114



Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
Times Cited: 65




List of shared articles



Times cited

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
3

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
Yi-Qing Lv, Lin Yuan, Yan Sun, Hao-Wen Dou, Ji-Hui Su, Zhi-Pan Hou, Jia-Yi Li, Wen Li. Transl Neurodegener 2022
3


The Impact of Type 2 Diabetes in Parkinson's Disease.
Dilan Athauda, James Evans, Anna Wernick, Gurvir Virdi, Minee L Choi, Michael Lawton, Nirosen Vijiaratnam, Christine Girges, Yoav Ben-Shlomo, Khalida Ismail,[...]. Mov Disord 2022
3

Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving.
Julienne Haas, Daniela Berg, Anja Bosy-Westphal, Eva Schaeffer. Nutrients 2022
0



Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease.
Ioanna Markaki, Theodora Ntetsika, Kimmo Sorjonen, Per Svenningsson. Mov Disord 2021
11

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
6

Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
Eduardo de Pablo-Fernández, Robert Courtney, Alice Rockliffe, Steve Gentleman, Janice L Holton, Thomas T Warner. Neuropathol Appl Neurobiol 2021
3

Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
2

Disease modifying therapies III: Novel targets.
Nirosen Vijiaratnam, Thomas Foltynie. Neuropharmacology 2021
3

Investigation of the Possible Correlation between Idiopathic Parkinson's Disease and Diabetes Mellitus in Egyptian Patients: A Pilot Study.
Afnan AwadAllah Elgnainy, Mohammad Ismail Hamed, Wael Osman Mohamed, Nagwa Ali Sabri. Neurol Res Int 2021
0


The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
46

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.
Iara Pérez-Taboada, Samuel Alberquilla, Eduardo D Martín, Rishi Anand, Stefania Vietti-Michelina, Nchimunya N Tebeka, James Cantley, Stephanie J Cragg, Rosario Moratalla, Mario Vallejo. Mov Disord 2020
20

Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease.
Xi Zhang, Yu Fan, Yuping Luo, Lingjing Jin, Siguang Li. Int J Med Sci 2020
4

Peripheral insulin and amylin levels in Parkinson's disease.
Almudena Sánchez-Gómez, Gema Alcarraz-Vizán, Manel Fernández, Rubén Fernández-Santiago, Mario Ezquerra, Ana Cámara, Mònica Serrano, Anna Novials, Esteban Muñoz, Francesc Valldeoriola,[...]. Parkinsonism Relat Disord 2020
10